Literature DB >> 11846524

Gene amplification in amphotericin B-resistant Leishmania tarentolae.

A K Singh1, B Papadopoulou, M Ouellette.   

Abstract

Two Leishmania tarentolae cells were selected step by step for resistance to the polyene antibiotic amphotericin B, a second-line drug against the parasite Leishmania. One of the mutants was cross-resistant to ketoconazole. DNA amplification was observed in both mutants. The amplicons were extrachromosomal circles and were derived from different chromosomes. In one mutant the circle was unusually stable as it remained within the cell despite numerous passages in the absence of the drug. A circumstantial link between the copy number of amplicons and the resistance levels was established. Gene transfection experiments indicated that the link between the locus amplified and the resistance levels was not straightforward and possibly several mutations act together to lead to amphotericin B resistance. Copyright 2001 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11846524     DOI: 10.1006/expr.2001.4663

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  12 in total

Review 1.  Drug resistance in leishmaniasis.

Authors:  Simon L Croft; Shyam Sundar; Alan H Fairlamb
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

2.  Unusual case of resistance to amphotericin B in visceral leishmaniasis in a region in India where leishmaniasis is not endemic.

Authors:  Pankaj Srivastava; Vijay Kumar Prajapati; Madhukar Rai; Shyam Sundar
Journal:  J Clin Microbiol       Date:  2011-05-25       Impact factor: 5.948

3.  Production and characterization of stable amphotericin-resistant amastigotes and promastigotes of Leishmania mexicana.

Authors:  Hamdan I Al-Mohammed; Michael L Chance; Paul A Bates
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

4.  Identification of new leishmanicidal peptide lead structures by automated real-time monitoring of changes in intracellular ATP.

Authors:  J Román Luque-Ortega; José M Saugar; Cristina Chiva; David Andreu; Luis Rivas
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

5.  Identification and chromosomal localization of one locus of Leishmania (L.) major related with resistance to itraconazole.

Authors:  L A Camizotti; E H Yamashiro-Kanashiro; Paulo C Cotrim
Journal:  Parasitol Res       Date:  2009-03-26       Impact factor: 2.289

6.  Cloning of S-adenosyl-L-methionine:C-24-Delta-sterol-methyltransferase (ERG6) from Leishmania donovani and characterization of mRNAs in wild-type and amphotericin B-Resistant promastigotes.

Authors:  Mohammad Pourshafie; Stanislas Morand; Alain Virion; Michaelle Rakotomanga; Corinne Dupuy; Philippe M Loiseau
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

7.  Genomic organization of leishmania species.

Authors:  B Kazemi
Journal:  Iran J Parasitol       Date:  2011-08       Impact factor: 1.012

Review 8.  Comparative analysis of the omics technologies used to study antimonial, amphotericin B, and pentamidine resistance in leishmania.

Authors:  Gagandeep Kaur; Bhawana Rajput
Journal:  J Parasitol Res       Date:  2014-05-12

9.  Treatment Outcome of the Drug-resistant Zoonotic Cutaneous Leishmaniasis by Glucantime.

Authors:  Simindokht Soleimanifard; Reza Arjmand; Sedighe Saberi; Mansoor Salehi; Seyed Hossain Hejazi
Journal:  Adv Biomed Res       Date:  2017-03-01

Review 10.  Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective.

Authors:  Om Prakash Singh; Bhawana Singh; Jaya Chakravarty; Shyam Sundar
Journal:  Infect Dis Poverty       Date:  2016-03-08       Impact factor: 4.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.